9-Jan-2026
No headlines found.
No press releases found.
No news found.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
Neuroone Medical Technologies trades on the NASDAQ stock market under the symbol NMTC.
As of January 9, 2026, NMTC stock price declined to $0.88 with 419,135 million shares trading.
NMTC has a beta of 2.44, meaning it tends to be more sensitive to market movements. NMTC has a correlation of 0.21 to the broad based SPY ETF.
NMTC has a market cap of $44.16 million. This is considered a Sub-Micro Cap stock.
Last quarter Neuroone Medical Technologies reported $3 million in Revenue and -$.04 earnings per share. This beat revenue expectation by $271,000 and met earnings estimates .
In the last 3 years, NMTC traded as high as $2.18 and as low as $.40.
The top ETF exchange traded funds that NMTC belongs to (by Net Assets): VTI, VXF.
NMTC has underperformed the market in the last year with a return of -18.9%, while the SPY ETF gained +19.0%. In the last 3 month period, NMTC fell short of the market, returning -15.0%, while SPY returned +3.7%. However, in the most recent 2 weeks NMTC has outperformed the stock market by returning +20.0%, while SPY returned +0.5%.
NMTC support price is $.82 and resistance is $.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NMTC shares will trade within this expected range on the day.
